Novo leans on brand loyalty, CV indications, and pipeline extensions to defend share
What the weight-loss industry has done brilliantly is to take credit for the first part of that biological response where people lose weight short term and blame their clients and get their clients to blame themselves for the second part of the same biological responsewhen they gain the weight back. Not repeating history Companies marketing and developing new drugs think they can overcome those long-standing issues plaguing the field
However, shortages and high costs have created significant barriers, prompting some patients to turn to compounded versions of these medications
Centrally Mediated Satiety (The Brain Connection) GLP-1 is capable of crossing the blood-brain barrier or signaling via the vagus nerve to reach the hypothalamus, the brains control center
While dry mouth, dehydration, and dietary changes associated with GLP-1 medications may contribute to breath odor, they are not always the only factors involved